Application
Western blot analysis of anti-IRS2 Antibody (C-term) in 293 cell line lysates (35ug/lane). IRS2 (arrow) was detected using the purified Pab.Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with IRS2 antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | IRS2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | IRS2; Insulin receptor substrate 2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:50~100 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | IRS2 Insulin receptor substrate 2 |
|---|---|
| Molecular Weight(MW) | 137334 Da |
| Function | May mediate the control of various cellular processes by insulin |
| Tissue Specificity | This IRS2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1309~1338 amino acids from the C-terminal region of human IRS2. |
| Cellular Localization | Cytoplasm, cytosol (By similarity). |
| Entrez Gene | 8660 |
|---|
Application
Western blot analysis of anti-IRS2 Antibody (C-term) in 293 cell line lysates (35ug/lane). IRS2 (arrow) was detected using the purified Pab.
Application
Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with IRS2 antibody (C-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | WB:1:50~100 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
